Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.

Bain, Stephen C et al.·Diabetes therapy : research·2025·
RPEP-100602025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.
Published In:
Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(1), 15-28 (2025)
Database ID:
RPEP-10060

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10060·https://rethinkpeptides.com/research/RPEP-10060

APA

Bain, Stephen C; Belmar, Nicolas; Hoff, Søren T; Husain, Mansoor; Rasmussen, Søren; Vilsbøll, Tina; Petrie, Mark C. (2025). Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(1), 15-28. https://doi.org/10.1007/s13300-024-01659-7

MLA

Bain, Stephen C, et al. "Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.." Diabetes therapy : research, 2025. https://doi.org/10.1007/s13300-024-01659-7

RethinkPeptides

RethinkPeptides Research Database. "Cardiovascular, Metabolic, and Safety Outcomes with Semaglut..." RPEP-10060. Retrieved from https://rethinkpeptides.com/research/bain-2025-cardiovascular-metabolic-and-safety

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.